AVXL
NASDAQ
US
Anavex Life Sciences Corp. - Common Stock
$2.99
▼ $-0.11
(-3.55%)
Vol 1.2M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$318.1M
ROE
-46.8%
D/E
0.00
Beta
1.18
52W
$3–$14
Wall Street Consensus
9 analysts · Apr 20262
Strong Buy
5
Buy
2
Hold
0
Sell
0
Strong Sell
77.8%
Buy Rating
Price Chart
Similar Stocks
RZLT
Rezolute Inc
$218.8M
OVID
Ovid Therapeutics Inc
$116.1M
FHTX
Foghorn Therapeutics Inc
$305.4M
ORGO
Organogenesis Holdings Inc
P/E 654.1
$657.4M
NBP
NovaBridge Biosciences
$458.9M
TARA
Protara Therapeutics Inc
$275.2M
CCCC
C4 Therapeutics Inc
$185.1M
ABEO
Abeona Therapeutics Inc
P/E 3.5
$285.6M
ALEC
Alector Inc
$170.3M
Earnings
Beat rate: 75.0%
Next Report
May 11, 2026
EPS Estimate: $-0.08
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Jun 2026 | $-0.08 | — | — |
| Dec 2025 | $-0.11 | $-0.06 | +$0.05 |
| Sep 2025 | $-0.15 | $-0.11 | +$0.04 |
| Jun 2025 | $-0.15 | $-0.16 | $-0.01 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -45.7% | -45.7% | -45.7% | -45.7% | -46.8% | -46.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 8.93 | 8.93 | 8.93 | 8.93 | 11.60 | 11.60 |
Key Ratios
ROA (TTM)
-41.5%
P/B
8.1
EPS (TTM)
$-0.54
52W High
$14.44
52W Low
$2.86
$2.86
52-Week Range
$14.44
How does AVXL compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
AVXL valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
8.1
▲
228%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
AVXL profitability vs Biotechnology peers
ROE
-46.8%
▲
30%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-41.5%
▲
11%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
AVXL financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
11.6
▲
161%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.2
▲
22%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
AVXL fundamentals radar
AVXL
Peer median
Industry
AVXL profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio